
GSK Patient Assistance Program for Vaccines
This section provides information about the GSK Patient Assistance Program for patients who need financial assistance with a GSK vaccine. This program does not constitute health insurance.
The following vaccines are currently included in the program:
- BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
- ENGERIX-B [Hepatitis B Vaccine (Recombinant)]
- SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
As of January 1, 2023, adult vaccines, specifically BOOSTRIX, ENGERIX B and SHINGRIX, will no longer be provided via the GSK Patient Assistance Program (PAP) for patients with Medicare coverage as a result of the enactment of the Inflation Reduction Act of 2022 (P.L. 117-169).